Pola Orbis Holdings Inc. (TYO:4927)
1,391.50
+8.00 (0.58%)
At close: Jan 23, 2026
Pola Orbis Holdings Revenue
Pola Orbis Holdings had revenue of 41.75B JPY in the quarter ending September 30, 2025, with 0.46% growth. This brings the company's revenue in the last twelve months to 169.97B, down -1.16% year-over-year. In the year 2024, Pola Orbis Holdings had annual revenue of 170.36B, down -1.70%.
Revenue (ttm)
169.97B
Revenue Growth
-1.16%
P/S Ratio
1.81
Revenue / Employee
42.27M
Employees
4,021
Market Cap
307.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170.36B | -2.95B | -1.70% |
| Dec 31, 2023 | 173.30B | 7.00B | 4.21% |
| Dec 31, 2022 | 166.31B | -12.34B | -6.90% |
| Dec 31, 2021 | 178.64B | 2.33B | 1.32% |
| Dec 31, 2020 | 176.31B | -43.61B | -19.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.21T |
| Lion Corporation | 416.73B |
| Rohto Pharmaceutical | 333.80B |
| KOSE Holdings | 324.54B |
| Earth | 177.37B |
| Kobayashi Pharmaceutical | 163.18B |
| Pigeon | 108.66B |
| MTG Co., Ltd. | 98.81B |